Company Filing History:
Years Active: 2012
Title: Kenneth Ian Cumming: Innovator in Nanoparticulate Compositions
Introduction
Kenneth Ian Cumming is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work on glipizide formulations. His expertise in nanoparticulate technology has paved the way for advancements in drug delivery systems.
Latest Patents
Kenneth holds a patent for "Glipizide compositions," which focuses on nanoparticulate compositions comprising glipizide. The invention emphasizes that the glipizide particles within the composition have an effective average particle size of less than about 2 microns. This innovation aims to enhance the bioavailability and efficacy of glipizide in therapeutic applications.
Career Highlights
Kenneth is associated with Alkermes Pharma Ireland Limited, where he applies his knowledge and skills to develop cutting-edge pharmaceutical solutions. His work has contributed to the company's reputation for innovation in drug formulation and delivery.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including H William Bosch and Niels Peter Ryde. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Kenneth Ian Cumming's contributions to nanoparticulate compositions exemplify the impact of innovation in the pharmaceutical industry. His work continues to influence the development of effective drug delivery systems, showcasing the importance of research and collaboration in advancing healthcare solutions.